BioAge Labs, Inc. Faces Class Action Lawsuit Following Stock Performance Decline
In recent developments, BioAge Labs, Inc. (NASDAQ: BIOA) has become the subject of a class action securities lawsuit. Law firm Levi & Korsinsky, LLP is leading this initiative, calling upon investors who may have incurr...
Feb 24, 2025
• Major Pharmaceutical Preparations Industry
Announcement
Class ActionRosen Law Firm New York Labs September